B cell intrinsic expression of IFNλ receptor suppresses the acute humoral immune response to experimental blood-stage malaria

References

• Murray CJL, Ortblad KF, Guinovart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. [Internet]. 2014;384(9947):1005–1070.
   Web of Science ®Google Scholar
• Weiss GE, Traore B, Kayentao K, et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010;6:e1000912.
   PubMed Web of Science ®Google Scholar
• Tran TM, Li S, Doumbo S, et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis. 2013;57:40–47.
   PubMed Web of Science ®Google Scholar
• Portugal S, Pierce SK, Crompton PD. Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol. 2013;190:3039–3046.
   PubMed Web of Science ®Google Scholar
• Raj DK, Nixon CP, Nixon CE, et al. Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection. Science. 2014;344(6186):871–877. .
   PubMed Web of Science ®Google Scholar
• Kinyanjui SM, Conway DJ, Lanar DE, et al. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J. 2007;6:82.
   PubMedGoogle Scholar
• Kinyanjui SM, Bull P, Newbold CI, et al. Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis. 2003;187:667–674.
   PubMed Web of Science ®Google Scholar
• Sze DM, Toellner KM, García de Vinuesa C, et al. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J Exp Med. 2000;192:813–821.
   PubMed Web of Science ®Google Scholar
• Suan D, Sundling C, Brink R. Plasma cell and memory B cell differentiation from the germinal center. Curr Opin Immunol. 2017;45:97–102.
   PubMed Web of Science ®Google Scholar
• Pape KA, Taylor JJ, Maul RW, et al. Different B cell populations mediate early and late memory during an endogenous immune response. Science. 2011;331:1203–1207.
   PubMed Web of Science ®Google Scholar
• Corcoran LM, Tarlinton DM. Regulation of germinal center responses, memory B cells and plasma cell formation-an update. Curr Opin Immunol. 2016;39:59–67.
   PubMed Web of Science ®Google Scholar
• Taylor JJ, Pape KA, Jenkins MK. A germinal center-independent pathway generates unswitched memory B cells early in the primary response. J Exp Med. 2012;209:597–606.
   PubMed Web of Science ®Google Scholar
• Moffett HF, Harms CK, Fitzpatrick KS, et al. B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4:eaax0644.
   PubMed Web of Science ®Google Scholar
• Taylor JJ, Pape KA, Steach HR, et al. Humoral immunity. Apoptosis and antigen affinity limit effector cell differentiation of a single naïve B cell. Science. 2015;347:784–787.
   PubMed Web of Science ®Google Scholar
• Harms Pritchard G, Pepper M. Memory B cell heterogeneity: remembrance of things past. J Leukoc Biol. 2018;103:269–274.
   PubMed Web of Science ®Google Scholar
• Yoon H-K, Shim Y-S, Kim P-H, et al. The TLR7 agonist imiquimod selectively inhibits IL-4-induced IgE production by suppressing IgG1/IgE class switching and germline ε transcription through the induction of BCL6 expression in B cells. Cell Immunol. 2019;338:1–8.
   PubMed Web of Science ®Google Scholar
• Syedbasha M, Egli A. Interferon lambda: modulating immunity in infectious diseases. Front Immunol. 2017;8:119.
   PubMed Web of Science ®Google Scholar
• Tran TM, Jones MB, Ongoiba A, et al. Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria. Sci Rep. 2016;6:31291.
   PubMed Web of Science ®Google Scholar
• Hillyer P, Mane VP, Schramm LM, et al. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol Cell Biol. 2012;90:774–783.
   PubMed Web of Science ®Google Scholar
• Shiow LR, Rosen DB, Brdicková N, et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440:540–544.
   PubMed Web of Science ®Google Scholar
• Gibb DR, Liu J, Santhanakrishnan M, et al. B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice. Transfusion. 2017;57:2595–2608.
   PubMed Web of Science ®Google Scholar
• Denton AE, Innocentin S, Carr EJ, et al. Type I interferon induces CXCL13 to support ectopic germinal center formation. J Exp Med. [Internet]. 2019;216(3):621–637.
   Web of Science ®Google Scholar
• Daugan M, Murira A, Mindt BC, et al. Type I interferon impairs specific antibody responses early during establishment of LCMV infection. Front Immunol. 2016;7:564.
   PubMed Web of Science ®Google Scholar
• Hahn WO, Butler NS, Lindner SE, et al. cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses. JCI Insight. 2018;3. [Internet]. DOI:https://doi.org/10.1172/jci.insight.94142
   Google Scholar
• Vigário AM, Belnoue E, Grüner AC, et al. Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J Immunol. 2007;178:6416–6425.
   PubMed Web of Science ®Google Scholar
• Morrell CN, Srivastava K, Swaim A, et al. Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun. 2011;79:1750–1758.
   PubMed Web of Science ®Google Scholar
• Wu J, Tian L, Yu X, et al. Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality. Proc Natl Acad Sci U S A. 2014;111:E511–20.
   PubMed Web of Science ®Google Scholar
• Zander RA, Guthmiller JJ, Graham AC, et al. Type I interferons induce T regulatory 1 responses and restrict humoral immunity during experimental malaria. PLoS Pathog. 2016;12:e1005945.
   PubMed Web of Science ®Google Scholar
• Sebina I, James KR, Soon MSF, et al. IFNAR1-signalling obstructs ICOS-mediated humoral immunity during non-lethal blood-stage plasmodium infection. PLoS Pathog. 2016;12:e1005999.
   PubMed Web of Science ®Google Scholar
• Obeng-Adjei N, Portugal S, Holla P, et al. Malaria-induced interferon-γ drives the expansion of Tbethi atypical memory B cells. PLoS Pathog. 2017;13:e1006576.
   PubMed Web of Science ®Google Scholar
• Ryg-Cornejo V, Ioannidis LJ, Ly A, et al. Severe malaria infections impair germinal center responses by inhibiting T follicular helper cell differentiation. Cell Rep. [Internet]. 2015. DOI:https://doi.org/10.1016/j.celrep.2015.12.006.
   Google Scholar
• Guthmiller JJ, Graham AC, Zander RA, et al. Cutting Edge: IL-10 Is essential for the generation of germinal center B cell responses and anti-plasmodium humoral immunity. J Immunol. 2017;198:617–622.
   PubMed Web of Science ®Google Scholar
• Domeier PP, Chodisetti SB, Soni C, et al. IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity. J Exp Med. 2016;213:715–732.
   PubMed Web of Science ®Google Scholar
• Jackson SW, Jacobs HM, Arkatkar T, et al. B cell IFN-γ receptor signaling promotes autoimmune germinal centers via cell-intrinsic induction of BCL-6. J Exp Med. 2016;213:733–750.
   PubMed Web of Science ®Google Scholar
• Rubtsova K, Rubtsov AV, Halemano K, et al. T cell production of IFNγ in Response to TLR7/IL-12 stimulates optimal B cell responses to viruses. PLoS One. 2016;11:e0166322.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Nice TJ, Diamond MS. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity. 2015;43:15–28.
   PubMed Web of Science ®Google Scholar
• Nice TJ, Baldridge MT, McCune BT, et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science. 2015;347:269–273.
   PubMed Web of Science ®Google Scholar
• Klinkhammer J, Schnepf D, Ye L, et al. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife. 2018;7. [Internet]. DOI:https://doi.org/10.7554/eLife.33354
   PubMed Web of Science ®Google Scholar
• de Groen RA, Groothuismink ZMA, Liu B-S BA. IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells. J Leukoc Biol. [Internet]. 2015. DOI:https://doi.org/10.1189/jlb.3A0215-041RR
   Google Scholar
• Egli A, Santer DM, O’Shea D, et al. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog. 2014;10:e1004556.
   PubMed Web of Science ®Google Scholar
• Misumi I, Whitmire JK. IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection. J Immunol. 2014;192:3596–3606.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Nishida N, Sugiyama M, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41:1105–1109.
   PubMed Web of Science ®Google Scholar
• Suppiah V, Moldovan M, Ahlenstiel G, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41:1100–1104.
   PubMed Web of Science ®Google Scholar
• Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461:399–401.
   PubMed Web of Science ®Google Scholar
• Chinnaswamy S. Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections. Genes Immun. 2016;17:265–275.
   PubMed Web of Science ®Google Scholar
• O’Brien TR, Pfeiffer RM, Paquin A, et al. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance. J Hepatol. 2015;63:1103–1110.
   PubMed Web of Science ®Google Scholar
• Egli A, Levin A, Santer DM, et al. Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirus. J Infect Dis. 2014;210:717–727.
   PubMed Web of Science ®Google Scholar
• Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol. 2003;4:69–77.
   PubMed Web of Science ®Google Scholar
• Peterson ST, Kennedy EA, Brigleb PH, et al. Disruption of type III interferon genes Ifnl2 and Ifnl3 recapitulates loss of the type III IFN receptor in the mucosal antiviral response. J Virol. [Internet]. 2019. DOI:https://doi.org/10.1128/JVI.01073-19.
   Google Scholar
• Djontu JC, Siewe Siewe S, Mpeke Edene YD, et al. Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate’s plasma levels of some cytokines known to regulate T cells differentiation and function. Malar J. 2016;15(1):561.
   PubMedGoogle Scholar
• Lazear HM, Daniels BP, Pinto AK, et al. Interferon-λ restricts West Nile virus neuroinvasion by tightening the blood-brain barrier. Sci Transl Med. 2015;7:284ra59.
   PubMed Web of Science ®Google Scholar
• Geurts N, Martens E, Verhenne S, et al. Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout mice. PLoS One. 2011;6:e27131.
   PubMed Web of Science ®Google Scholar
• Yilmaz B, Portugal S, Tran TM, et al. Gut microbiota elicits a protective immune response against malaria transmission. Cell. 2014;159:1277–1289.
   PubMed Web of Science ®Google Scholar
• Choudhury HR, Sheikh NA, Bancroft GJ, et al. Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect Immun. 2000;68:6127–6132.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Hafalla JCR, et al. Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia. Infect Immun. 2007;75:5806–5818.
   PubMed Web of Science ®Google Scholar
• Vigário AM, Belnoue E, Cumano A, et al. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood. 2001;97:3966–3971.
   PubMed Web of Science ®Google Scholar
• Grun JL, Weidanz WP. Antibody-independent immunity to reinfection malaria in B-cell-deficient mice. Infect Immun. 1983;41:1197–1204.
   PubMed Web of Science ®Google Scholar
• Krishnamurty AT, Thouvenel CD, Portugal S, et al. Somatically hypermutated plasmodium-specific IgM(+) memory B cells are rapid, plastic, early responders upon malaria rechallenge. Immunity. 2016;45:402–414.
   PubMed Web of Science ®Google Scholar
• White WI, Evans CB, Taylor DW. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect Immun. 1991;59:3547–3554.
   PubMed Web of Science ®Google Scholar
• Borges da Silva H, Machado de Salles É, Lima-Mauro EF, et al. CD28 deficiency leads to accumulation of germinal-center independent IgM+ experienced B cells and to production of protective IgM during experimental malaria. PLoS One. 2018;13:e0202522.
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson T-R, Phillips P. Infective dose modulates the balance between Th1- and Th2-regulated immune responses during blood-stage malaria infection. Scand J Immunol. 1998;48(5):527–534.
   PubMed Web of Science ®Google Scholar
• Galani IE, Triantafyllia V, Eleminiadou -E-E, et al. Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity. 2017;46:875–90.e6.
   PubMed Web of Science ®Google Scholar
• Redeker A, Welten SPM, Arens R. Viral inoculum dose impacts memory T-cell inflation. Eur J Immunol. 2014;44:1046–1057.
   PubMed Web of Science ®Google Scholar
• Ellebedy AH, Jackson KJL, Kissick HT, et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat Immunol. 2016;17:1226–1234.
   PubMed Web of Science ®Google Scholar
• Kalinke U, Bucher EM, Ernst B, et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity. 1996;5:639–652.
   PubMed Web of Science ®Google Scholar
• Borges da Silva H, Fonseca R, Cassado ADA, et al. In vivo approaches reveal a key role for DCs in CD4+ T cell activation and parasite clearance during the acute phase of experimental blood-stage malaria. PLoS Pathog. 2015;11:e1004598.
   PubMed Web of Science ®Google Scholar
• Roberts DW, Rank RG, Weidanz WP, et al. Prevention of recrudescent malaria in nude mice by thymic grafting or by treatment with hyperimmune serum. Infect Immun. 1977;16:821–826.
   PubMed Web of Science ®Google Scholar
• Phillips S, Mistry S, Riva A, et al. Peg-interferon lambda treatment induces robust innate and adaptive immunity in chronic hepatitis B patients. Front Immunol. 2017;8:621.
   PubMed Web of Science ®Google Scholar
• MKL M, McKee A, Crawford F, et al. CD4 memory T cells divide poorly in response to antigen because of their cytokine profile. Proc Natl Acad Sci U S A. 2008;105:14521–14526.
   PubMed Web of Science ®Google Scholar
• Pepper M, Pagán AJ, Igyártó BZ, et al. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity. 2011;35:583–595.
   PubMed Web of Science ®Google Scholar
• Hemann EA, Green R, Turnbull JB, et al. Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus. Nat Immunol. [Internet]. 2019;20(8):1035–1045.
   PubMed Web of Science ®Google Scholar
• Kelly A, Robinson MW, Roche G, et al. Immune cell profiling of IFN-λ response shows pDCs express highest level of IFN-λR1 and are directly responsive via the JAK-STAT pathway. J Interferon Cytokine Res. [Internet]. 2016;36(12):671–680.
   PubMed Web of Science ®Google Scholar
• Amante FH, Good MF. Prolonged Th1-like response generated by a Plasmodium yoelii-specific T cell clone allows complete clearance of infection in reconstituted mice. Parasite Immunol. 1997;19:111–126.
   PubMed Web of Science ®Google Scholar
• Baldridge MT, Lee S, Brown JJ, et al. Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of IFN-lambda against norovirus and reovirus. J Virol. [Internet]. 2017. DOI:https://doi.org/10.1128/JVI.02079-16
   Google Scholar
• Hobeika E, Thiemann S, Storch B, et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc Natl Acad Sci U S A. 2006;103:13789–13794.
   PubMed Web of Science ®Google Scholar
• Couper KN, Blount DG, Wilson MS, et al. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 2008;4:e1000004.
   PubMed Web of Science ®Google Scholar
• Broggi A, Tan Y, Granucci F, et al. IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function. Nat Immunol. [Internet]. 2017;18(10):1084–1093.
   PubMed Web of Science ®Google Scholar
• Chrysanthopoulou A, Kambas K, Stakos D, et al. Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation. J Pathol. [Internet]. 2017;243(1):111–122.
   PubMed Web of Science ®Google Scholar
• Ouyang W, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29(1):71–109.
   PubMedGoogle Scholar
• Banchereau R, Hong S, Cantarel B, et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell. 2016;165:551–565.
   PubMed Web of Science ®Google Scholar
• Günther C, Ruder B, Stolzer I, et al. Interferon lambda promotes paneth cell death via STAT1 signaling in mice and is increased in inflamed ileal tissues of patients with crohn’s disease. Gastroenterology. [Internet]. 2019;157(5):1310–1322.e13.
   PubMed Web of Science ®Google Scholar
• Jordan WJ, Eskdale J, Srinivas S, et al. Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response. Genes Immun. 2007;8(3):254–261.
   PubMed Web of Science ®Google Scholar
• Dai J, Megjugorac NJ, Gallagher GE, et al. IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells. Blood. 2009;113:5829–5838.
   PubMed Web of Science ®Google Scholar
• Nordström I, Eriksson K. HHV-6B induces IFN-lambda1 responses in cord plasmacytoid dendritic cells through TLR9. PLoS One. 2012;7:e38683.
   PubMed Web of Science ®Google Scholar
• Arasteh J, Ebtekar M, Pourpak Z, et al. The effect of IL-28A on human cord blood CD4+ T cells. Immunopharmacol Immunotoxicol. 2010;32:339–347.
   PubMed Web of Science ®Google Scholar
• van der Heyde HC, DD M, DC R, et al. Resolution of blood-stage malarial infections in CD8+ cell-deficient beta 2-m0/0 mice. J Immunol. 1993;151:3187–3191.
   PubMed Web of Science ®Google Scholar
• Weidanz WP, Melancon-Kaplan J, Cavacini LA. Cell-mediated immunity to the asexual blood stages of malarial parasites: animal models. Immunol Lett. 1990;25:87–95.
   PubMed Web of Science ®Google Scholar
• Vinetz JM, Kumar S, Good MF, et al. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage plasmodium yoelii malaria. J Immunol. 1990;144:1069–1074.
   PubMed Web of Science ®Google Scholar
• Imai T, Ishida H, Suzue K, et al. Cytotoxic activities of CD8+ T cells collaborate with macrophages to protect against blood-stage murine malaria. Elife. 2015;4. [Internet]. DOI:https://doi.org/10.7554/eLife.04232
   PubMed Web of Science ®Google Scholar
• Imai T, Suzue K, Ngo-Thanh H, et al. Fluctuations of spleen cytokine and blood lactate, importance of cellular immunity in host defense against blood stage malaria plasmodium yoelii. Front Immunol. 2019;10:2207.
   PubMed Web of Science ®Google Scholar
• Horne-Debets JM, Karunarathne DS, Faleiro RJ, et al. Mice lacking Programmed cell death-1 show a role for CD8(+) T cells in long-term immunity against blood-stage malaria. Sci Rep. 2016;6:26210.
   PubMed Web of Science ®Google Scholar
• Forero A, Ozarkar S, Li H, et al. Differential activation of the transcription factor IRF1 underlies the distinct immune responses elicited by Type I and Type III interferons. Immunity. [Internet]. 2019;51(3):451–464.e6.
   PubMed Web of Science ®Google Scholar
• Ye L, Schnepf D, Becker J, et al. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin. Nat Immunol. 2019;20:593–601.
   PubMed Web of Science ®Google Scholar
• Ye L, Ohnemus A, Ong LC, et al. Type I and type III interferons differ in their adjuvant activities for influenza vaccines. J Virol. [Internet]. 2019;93. DOI:https://doi.org/10.1128/JVI.01262-19
   Google Scholar
• Moon JJ, Chu HH, Hataye J, et al. Tracking epitope-specific T cells. Nat Protoc. 2009;4:565–581.
   PubMed Web of Science ®Google Scholar
• Keitany GJ, Kim KS, Krishnamurty AT, et al. Blood stage malaria disrupts humoral immunity to the pre-erythrocytic stage circumsporozoite P rotein. Cell Rep. 2016;17:3193–3205.
   PubMed Web of Science ®Google Scholar
• Taylor JJ, Martinez RJ, Titcombe PJ, et al. Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen. J Exp Med. 2012;209:2065–2077.
   PubMed Web of Science ®Google Scholar